Purpose
Optimizing return to work after knee arthroplasty becomes more important because of the growing incidence of KA among workers and poor return to work outcomes. The purpose of this study is to investigate the feasibility of Back At work After Surgery (BAAS): an integrated clinical pathway for return to work after knee arthroplasty.
Method
Working patients who received unicompartmental knee arthroplasty (UKA) or total knee arthroplasty (TKA) between January 2021 and November 2021, younger than 65 years and motivated to return to work were eligible to participate. Feasibility was investigated on five domains: reach, dose delivered, dose received, fidelity and patients’ attitudes. These outcomes were obtained by a patient-reported questionnaire and an interview with the case manager occupation and case manager medical.
Results
Of the eligible 29 patients, eleven were willing to participate (response rate 29%; due to travel distance to and from the hospital). The reach from professionals was 100%. The dose delivered between 91–100%, except information given about return to work from the orthopedic surgeon which was 18%. The dose received was 100%. For fidelity, case managersreported nine shortcomings for which five solutions were mentioned. In terms of patients’ attitude, all patients were satisfied and one patient mentioned an improvement.
Conclusions
In terms of reach, participation was low: only 29%. In terms of dose delivered, dose received, fidelity and patient attitudes of the BAAS clinical pathway seems feasible. The next step will be to assess the effectiveness of the BAAS clinical pathway for return to work.